<PAGE> 1
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check One):
[ ] Form 10-K and Form 10-KSB [ ] Form 20-F [ ] Form 11-K
[X] Form 10-Q and Form 10-QSB [ ] Form N-SAR
For Period Ended: March 31, 1996
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:_______________________________________
________________________________________________________________________________
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates: Item 8, Part II,
Financial Statements.
PART I - REGISTRANT INFORMATION
________________________________________________________________________________
Full Name of Registrant: Medizone International, Inc.
Former Name if Applicable: (originally, Madison Funding, Inc.)
123 East 54th Street
Address of Principal Executive Office (Street and Number)
New York, New York 10022
City, State and Zip Code
________________________________________________________________________________
PART II - RULES 12b-25(b) AND (c)
________________________________________________________________________________
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b) the following should
be completed. (Check box if appropriate).
[ X ] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
[ X ] (b) The subject annual report, semi-annual report, transition report on
Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or
before the fifteenth calendar day following the prescribed due date; or the
subject quarterly report or transition report on Form 10-Q, or portion thereof
will be filed on or before the fifth calendar day following the prescribed due
date; and
<PAGE> 2
[ ] (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
________________________________________________________________________________
PART III - NARRATIVE
________________________________________________________________________________
Certain of the financial information required to be included in the registrant's
quarterly report on Form 10-Q for the period ended March 31, 1996 could not be
obtained in a timely manner without the unreasonable expense and effort on the
part of the registrant.
________________________________________________________________________________
PART IV - OTHER INFORMATION
________________________________________________________________________________
(1) Name and telephone number of person to contact in regard to
this notification
Andrew E. Goldstein, Esq. (212) 826-2000
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under section 13 or
15(d) of the Securities Exchange Act of 1934 or section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter period
that the registrant was required to file such report(s) been filed? If the
answer is no, identify report(s).
[ X ] Yes [ ] No
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or
portion thereof?
[ ] Yes [ X ] No
If so; attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
Medizone International, Inc.
(Name of Registrant as specific in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date May 15, 1996 By /s/ Arthur P. Bergeron
----------------------------------------
Arthur P. Bergeron, Vice President,
Treasurer and Chief Financial Officer
